Physician profile
James P Davies
NPI 1881034726
$14,695.11
in general payments reported to CMS, 2019-2025
26 companies · $1,006 in 2025
The $1,006 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,356 · 2020: $907 · 2021: $2,110 · 2022: $1,539 · 2023: $3,036 · 2024: $1,741 · 2025: $1,006.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,246 · Travel and Lodging: $2,538.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,245.88 |
| Travel and Lodging | $2,537.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $5,271.10 | 2019-2024 | Distal Extremities Implants Trauma |
| Pylant Medical | $1,942.55 | 2020-2024 | |
| Stryker Corporation | $1,756.09 | 2020-2025 | Infinity Adaptis, Prophecy, Ortholoc 3di |
| Edwards Lifesciences Corporation | $1,407.18 | 2019-2020 | |
| Exactech, INC. | $1,352.57 | 2023 | |
| Organogenesis INC. | $595.29 | 2021-2025 | Via Matrix, Puraply Wound Matrix, Simplimax |
| Wright Medical Technology, INC. | $582.92 | 2019-2020 | |
| Extremity Medical | $360.00 | 2019 | |
| Smith+Nephew, INC. | $268.89 | 2020-2025 | Collagenase Santyl, Evos, Grafix Pl |
| Treace Medical Concepts, INC. | $207.75 | 2022-2025 | |
| Biotissue Holdings INC. | $130.18 | 2025 | |
| Paragon 28, INC. | $122.00 | 2021 | |
| Amgen INC. | $118.07 | 2025 | Evenity |
| Zimmer Biomet Holdings, INC. | $111.87 | 2020 | |
| Depuy Synthes Sales INC. | $79.43 | 2019-2025 | Motoband Cp, N/A, Motoband |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $71.36 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Integra Lifesciences Corporation | $58.07 | 2023 | Tenoglide |
| Vertex Pharmaceuticals Incorporated | $52.22 | 2025 | |
| Crossroads Extremity Systems, LLC | $44.60 | 2019 | |
| Polynovo North America LLC | $35.24 | 2023 | |
| Acera Surgical, INC. | $24.87 | 2024 | Restrata Wound Matrix |
| Medline Industries LP | $24.37 | 2024 | |
| Dynasplint Systems INC. | $21.99 | 2023 | Dynasplint |
| Pacira Pharmaceuticals Incorporated | $20.10 | 2024 | Iovera, Zilretta |
| Heron Therapeutics, INC. | $18.85 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $17.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Davies listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.